One vector targets two genes, creating a combinatorial knockout to speed up the pace of genomic discoveries HUNTSVILLE, Ala. — The simultaneous knockout of two genes can help identify functional relationships between genes, which can lead to a better understanding of biological systems and can have direct implications for cancer therapeutic development as well as other […]
HATFIELD, Pa. — Genisphere LLC, provider of the 3DNA® drug delivery platform, has signed a collaborative and sponsored research agreement with the University of Maryland, through Dr. Silvia Muro. The overall goal of the partnership is to study the pharmacokinetics and pharmacodynamics of various 3DNA designs and formulations after in vivo administration. Additional aims involve targeting diseases […]
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has non-exclusively licensed its patented stochastic labelling technology to Roche for multiple commercial applications. BD’s patented stochastic labelling technology incorporating molecular indexes (known also as UMIs or molecular barcodes), enables the precise counting of individual biological […]
CORNING, N.Y. | CORNING INCORPORATED | Corning Incorporated (NYSE: GLW) has expanded its ADME/Tox product offerings to include Corning®TransportoCells™ HEK293-derived ABC transporter membrane vesicles and Corning Supersomes™ Ultra Human Aldehyde Oxidase (AO) enzyme. Building on its large line of Corning Gentest™ in vitro transporter models, TransportoCells provide an innovative cell model for solute carrier (SLC) transporter studies. Corning has now developed ATP-binding cassette […]
Agreement includes exclusive distribution of PurePep Coupling Agents in North America Uppsala, Sweden, 25 April 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has signed an exclusive distribution agreement with Luxembourg Bio Technologies for two of its proprietary coupling agents, […]
New SureSeq myPanel™ NGS Custom Cancer Panel content covers a wider range of cancer types with excellent coverage uniformity for confident results. Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its SureSeq myPanel™ NGS Custom Cancer Panel content. The expansion comes in response to NGS becoming ever more important for research […]
The new VIPS system is the second major product line launched by Solentim Bournemouth, UK – Solentim, the developer of instrumentation for cell line development, today announced the addition of a major new product line called the VIPS™ (‘Validated In-situ Plate Seeding’). The VIPS has been developed for automatically seeding single cells into 96 and 384 […]
• Current OEM agreement expanded to cover two additional product lines • Expected annual revenue contribution now more than EUR 1M Madrid, Spain, and Heidelberg, Germany, April 24, 2017 – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced the successful completion of a second contract with TANON, the leading Chinese proteomics company. The […]
SYDNEY, AUSTRALIA and SOUTH SAN FRANCISCO, CA—SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has signed an agreement with Thermo Fisher Scientific, the world leader in serving science, in support of SpeeDx’s plan to submit its ResistancePlus™ MG Test for clearance by the U.S. Food & Drug Administration (FDA). Under the terms of […]
Oxford Nanopore has launched a new analytical workflow for use with its real time nanopore sequencing devices. ‘ARMA’ allows characterisation of antimicrobial resistance genes in real time. The movie below shows real time analysis of pathogen DNA using two conjoined workflows: ‘What’s in my Pot’ (WIMP) is used for taxonomic classification of pathogens in a sample, […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
